(Journal of Cardiology, 2008) Beneficial effects of beta-blockers and angiotensin-converting enzyme inhibitors in Duchenne muscular dystrophy Hitoko Ogata (MD, FJCC), Yuka Ishikawa (MD), Yukitoshi Ishikawa (MD), Ryoji Minami (MD) - Japan Background: Patients with Duchenne muscular dystrophy (DMD) often have severe heart failure with a high mortality rate. Most DMD patients with cardiomyopathy b…